Cargando…

Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy

BACKGROUND: To investigate the impact of programmed death‐ligand 1 (PD‐L1) polymorphisms on the prognosis of non‐small cell lung cancer (NSCLC) patients treated with curative radiotherapy. METHODS: Four single nucleotide polymorphisms (SNPs) (rs822336G>C, rs822337T>A, rs822338C>T, and rs229...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Min Kyu, Lee, Shin Yup, Choi, Jin Eun, Do, Sook Kyung, Cho, Moon‐June, Kim, Jun‐Sang, Park, Jae Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607250/ https://www.ncbi.nlm.nih.gov/pubmed/34612596 http://dx.doi.org/10.1002/cam4.4329

Ejemplares similares

Prognostic significance of genetic variants in GLUT1 in stage III non‐small cell lung cancer treated with radiotherapy
por: Kang, Min Kyu, et al.
Publicado: (2021)

Immune implication of an autophagy-related prognostic signature in uveal melanoma
por: Chuah, Samuel, et al.
Publicado: (2021)

PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy
por: Lee, Shin Yup, et al.
Publicado: (2016)

Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis
por: Li, Xiao-Song, et al.
Publicado: (2020)

Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
por: Jeong, Hyehyun, et al.
Publicado: (2021)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
por: Glynn, Aisling M., et al.
Publicado: (2019)

The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma
por: Park, Eun‐Ran, et al.
Publicado: (2017)

Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
por: Weber, Manuel, et al.
Publicado: (2019)

Baseline monocyte and its classical subtype may predict efficacy of PD-1/PD-L1 inhibitor in cancers
por: Shao, Yilin, et al.
Publicado: (2021)

Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma
por: Lee, Ji Won, et al.
Publicado: (2020)

Prognostic Impact of Sarcopenia and Radiotherapy in Patients With Advanced Gastric Cancer Treated With Anti-PD-1 Antibody
por: Kim, Nalee, et al.
Publicado: (2021)

The prognostic role of soluble TGF‐beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy
por: Park, Hyunkyung, et al.
Publicado: (2019)

Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer
por: Chen, Yu, et al.
Publicado: (2021)

TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population
por: Yoo, Seung Soo, et al.
Publicado: (2015)

Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model‐based analysis
por: Seo, Young‐Seok, et al.
Publicado: (2016)

Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes
por: Ni, Yunbi, et al.
Publicado: (2022)

Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer
por: Park, In Kyu, et al.
Publicado: (2021)

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
por: Kim, Chan, et al.
Publicado: (2016)

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

Prognostic implications of peritumoral vasculature in head and neck cancer
por: Evans, Michael, et al.
Publicado: (2018)

Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single‐arm study
por: Pan, Zhenyu, et al.
Publicado: (2016)

Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging
por: Xu, Hongyao, et al.
Publicado: (2019)

Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy
por: Wu, Yao‐Yu, et al.
Publicado: (2021)

Safety and Efficacy of PD‐1/PD‐L1 inhibitors combined with radiotherapy in patients with non‐small‐cell lung cancer: a systematic review and meta‐analysis
por: Geng, Yichao, et al.
Publicado: (2021)

Prostasin regulates PD-L1 expression in human lung cancer cells
por: Chen, Li-Mei, et al.
Publicado: (2021)

Dysregulation, functional implications, and prognostic ability of the circadian clock across cancers
por: Liu, Zekun, et al.
Publicado: (2019)

Prognostic significance of the radiologic features of pneumonitis induced by anti‐PD‐1 therapy
por: Watanabe, Satoshi, et al.
Publicado: (2020)

Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
por: Aas, Kirsti, et al.
Publicado: (2021)

The impact of expanding health insurance coverage for anti‐cancer drugs on cancer survival in Korea
por: Cho, Do‐Yeon, et al.
Publicado: (2021)

PD-L1 regulates tumorigenesis and autophagy of ovarian cancer by activating mTORC signaling
por: Gao, Hongmin, et al.
Publicado: (2019)

A six-gene-based signature for breast cancer radiotherapy sensitivity estimation
por: Chen, Xing, et al.
Publicado: (2020)

Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma
por: Margalit, Ofer, et al.
Publicado: (2020)

The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
por: Hjelle, Line V., et al.
Publicado: (2023)

Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis
por: Chao, Ce, et al.
Publicado: (2019)

Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes
por: Lou, Jiaying, et al.
Publicado: (2021)

Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy
por: Jeong, Jae-Uk, et al.
Publicado: (2019)

BCR‐ABL1 transcript levels at 4 weeks have prognostic significance for time‐specific responses and for predicting survival in chronic‐phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
por: Song, Hye‐young, et al.
Publicado: (2018)

Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
por: Wang, Zhiwu, et al.
Publicado: (2020)

Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus
por: Derby, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h11nu5t176ga70cbl7p706i66j